Mandate

Vinge has advised Embracer Group in connection with a EUR 600 million multicurrency revolving facility agreement

July 19, 2024 M&A

Vinge has advised Embracer Group in connection with a EUR 600 million multicurrency revolving facility agreement entered into with BNP Paribas, Citibank Europe, DNB, JP Morgan, Nordea, SEB and Swedbank.

Vinge has advised Embracer Group AB (publ) (“Embracer”) in connection with the entry into of a EUR 600 million financing agreement with BNP Paribas, Citibank Europe, DNB, JP Morgan, Nordea, SEB and Swedbank. Embracer is a global group of entrepreneurial businesses in the gaming and entertainment industry.

The new facility of EUR 600 million is used to refinance Embracer’s existing revolving credit facilities of SEK 4.8 billion. The terms and conditions for the new facility have been improved, including a notably lower credit margin for utilised debt, which will reduce interest expenses through both improved terms and a reduced financial leverage.

Vinge’s team consisted of Albert Wållgren, Felix Möller, Ida Redander and Josef Groow.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025